These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23832090)

  • 41. In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.
    Matsumoto S; Saito K; Takakusagi Y; Matsuo M; Munasinghe JP; Morris HD; Lizak MJ; Merkle H; Yasukawa K; Devasahayam N; Suburamanian S; Mitchell JB; Krishna MC
    Antioxid Redox Signal; 2014 Sep; 21(8):1145-55. PubMed ID: 24597714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.
    Galiè M; Farace P; Nanni C; Spinelli A; Nicolato E; Boschi F; Magnani P; Trespidi S; Ambrosini V; Fanti S; Merigo F; Osculati F; Marzola P; Sbarbati A
    Neoplasia; 2007 Nov; 9(11):900-8. PubMed ID: 18030358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
    Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
    J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.
    He F; Deng X; Wen B; Liu Y; Sun X; Xing L; Minami A; Huang Y; Chen Q; Zanzonico PB; Ling CC; Li GC
    Cancer Res; 2008 Oct; 68(20):8597-606. PubMed ID: 18922936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [PET evaluation of glucose metabolism in cancer].
    Yasuda S; Fujii H; Takahashi W; Takagi S; Ide M; Shohtsu A
    Gan To Kagaku Ryoho; 1999 May; 26(6):756-61. PubMed ID: 10410143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.
    Clavo AC; Brown RS; Wahl RL
    J Nucl Med; 1995 Sep; 36(9):1625-32. PubMed ID: 7658223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Posthypoxic reoxygenation-induced neurotoxicity prevented by free radical scavenger and NMDA/non-NMDA antagonist in tandem as revealed by dynamic changes in glucose metabolism with positron autoradiography.
    Murata T; Omata N; Fujibayashi Y; Waki A; Sadato N; Yoshimoto M; Wada Y; Yonekura Y
    Exp Neurol; 2000 Aug; 164(2):269-79. PubMed ID: 10915566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
    Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
    Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.
    Kim TH; Yoon JK; Kang DK; Lee SJ; Jung YS; Yim H; An YS
    Ann Surg Oncol; 2015 Nov; 22(12):3866-72. PubMed ID: 25805237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the metabolic microenvironment of tumors.
    Bailey KM; Wojtkowiak JW; Hashim AI; Gillies RJ
    Adv Pharmacol; 2012; 65():63-107. PubMed ID: 22959024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
    Busk M; Walenta S; Mueller-Klieser W; Steiniche T; Jakobsen S; Horsman MR; Overgaard J
    Radiother Oncol; 2011 Jun; 99(3):404-11. PubMed ID: 21704401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose Infusion Induced Change in Intracellular pH and Its Relationship with Tumor Glycolysis in a C6 Rat Model of Glioblastoma.
    Qi Q; Fox MS; Lim H; Sullivan R; Li A; Bellyou M; Desjardins L; McClennan A; Bartha R; Hoffman L; Scholl TJ; Lee TY; Thiessen JD
    Mol Imaging Biol; 2023 Apr; 25(2):271-282. PubMed ID: 36418769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo magnetic resonance imaging of glucose - initial experience.
    Allouche-Arnon H; Wade T; Waldner LF; Miller VN; Gomori JM; Katz-Brull R; McKenzie CA
    Contrast Media Mol Imaging; 2013; 8(1):72-82. PubMed ID: 23109395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
    BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
    Goetze K; Fabian CG; Siebers A; Binz L; Faber D; Indraccolo S; Nardo G; Sattler UG; Mueller-Klieser W
    Cell Oncol (Dordr); 2015 Oct; 38(5):377-85. PubMed ID: 26288178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multimodality assessment of brain tumors and tumor recurrence.
    Heiss WD; Raab P; Lanfermann H
    J Nucl Med; 2011 Oct; 52(10):1585-600. PubMed ID: 21840931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
    Lindholm P; Sutinen E; Oikonen V; Mattila K; Tarkkanen M; Kallajoki M; Aro H; Böhling T; Kivioja A; Elomaa I; Minn H
    Nucl Med Biol; 2011 Feb; 38(2):295-300. PubMed ID: 21315286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.
    Hatano T; Zhao S; Zhao Y; Nishijima K; Kuno N; Hanzawa H; Sakamoto T; Tamaki N; Kuge Y
    Int J Oncol; 2013 Mar; 42(3):823-30. PubMed ID: 23338175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.
    Apostolova I; Hofheinz F; Buchert R; Steffen IG; Michel R; Rosner C; Prasad V; Köhler C; Derlin T; Brenner W; Marnitz S
    Strahlenther Onkol; 2014 Jun; 190(6):575-81. PubMed ID: 24535649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.